Lisata Therapeutics, Inc.

LSTACIK 0000320017 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 28, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0063

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Jun 1, 20268.01 · Other Events May 29, 20261.01 · Entry into a Material Definitive Agreeme9.01 · Financial Statements and Exhibits May 4, 2026no items parsed Apr 15, 2026no items parsed Apr 3, 2026no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Lisata Therapeutics, Inc.

Name	Roles	Filings
Azab Mohammad	Director	4
Henson Heidi	Director	4
Nisco James	Officer	3
Girolamo Todd C	Officer	2
Davidson Michael H.	Director	1

Showing 6-10 of 16

Per pagePrevPage 2 of 4Next

All filings

52 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Jan 11, 2023	Ruoslahti Erkki Director	AGrant	20,000	$0.00	$0
Jan 11, 2023	Brown Gregory B Director	AGrant	20,000	$0.00	$0
Jan 11, 2023	Flowers Cynthia Louise Director	AGrant	20,000	$0.00	$0
Jan 11, 2023	Buck Kristen K EVP, R&D and CMO	FTax	2,147	$3.00	$6,441
Jan 11, 2023	Slack David W. President & CBO · Director	FTax	3,358	$3.00	$10,074

Showing 36-40 of 52

Per pagePrevPage 8 of 11Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value